Citius Pharmaceuticals (CTXR) Earnings Date, Estimates & Call Transcripts $0.40 +0.02 (+5.83%) (As of 03:45 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Citius Pharmaceuticals Latest Earnings SummaryUpcoming Earnings DateJan. 3EstimatedActual EPS (Aug. 12) -$0.06 Missed By -$0.01 Consensus EPS (Aug. 12) -$0.05 Citius Pharmaceuticals released Q2 2024 earnings on August 12, 2024, reporting an EPS of -$0.06, which missed analysts' consensus estimates of -$0.05 by $0.01. With a trailing EPS of -$0.24, Citius Pharmaceuticals' earnings are expected to grow next year, from ($0.21) to $0.09 per share. Earnings Press ReleaseCTXR Upcoming EarningsCitius Pharmaceuticals' next earnings date is estimated for Friday, January 3, 2025, based off prior year's reporting schedules. Get Citius Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Citius Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCTXR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CTXR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link Citius Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.21) EPSNext Year EPS Consensus Estimate: $0.09 EPS Citius Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 1/3/2025(Estimated)------- 8/12/2024--$0.05-$0.06 -$0.01-$0.06-- 5/14/2024Q2 2024-$0.06-$0.05+$0.01-$0.05-- 2/14/2024Q1 2024$0.13-$0.06 -$0.19-$0.06-- 12/29/2023Q4 2023-$0.02-$0.07 -$0.05-$0.07-- 8/14/2023Q3 2023-$0.06-$0.06--$0.06-- 5/12/2023Q2 2023-$0.04-$0.07 -$0.03-$0.07-- Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/10/2023Q1 2023--$0.04 -$0.04-$0.06-- 12/22/2022Q4 2022-$0.04-$0.05 -$0.01-$0.05-- Citius Pharmaceuticals Earnings - Frequently Asked Questions When is Citius Pharmaceuticals's earnings date? Citius Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based off last year's report dates. Learn more on CTXR's earnings history. Did Citius Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Citius Pharmaceuticals (NASDAQ:CTXR) missed the analysts' consensus estimate of ($0.05) by $0.01 with a reported earnings per share (EPS) of ($0.06). Learn more on analysts' earnings estimate vs. CTXR's actual earnings. How much profit does Citius Pharmaceuticals generate each year? Citius Pharmaceuticals (NASDAQ:CTXR) has a recorded net income of -$32.54 million. CTXR has generated -$0.24 earnings per share over the last four quarters. What is Citius Pharmaceuticals's EPS forecast for next year? Citius Pharmaceuticals's earnings are expected to grow from ($0.21) per share to $0.09 per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Vistagen Therapeutics Earnings Daré Bioscience Earnings Merrimack Pharmaceuticals Earnings Sutro Biopharma Earnings TScan Therapeutics Earnings Lexeo Therapeutics Earnings Acrivon Therapeutics Earnings MacroGenics Earnings Amarin Earnings Editas Medicine Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Could TSLA reach $500 a share? Free ebook says it’s possible. (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link This page (NASDAQ:CTXR) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
